Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole
Completed · Phase 1
Conditions studied: Healthy Participants
In brief
The primary objective of the trial is to assess the effect of multiple doses of the cytochrome P450 (CYP3A4) enzyme inducer carbamazepine (Part A) or the CYP3A4 inhibitor itraconazole (Part B) on the single-dose pharmacokinetics (PK) of AP31969 in healthy participants.
Key facts
- Study ID
- NCT07449390
- Run by
- Acesion Pharma
- People needed
- 28
- Starts
- 2026-04-01
- Expected to finish
- 2026-05-16
- Last updated by the study team
- 2026-05-22
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- ICON Early Phase Services, LLC — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.